Provision and delivery of survivorship care for adult patients with haematological malignancies: A scoping review protocol

Author:

Baldwin Zoe-Anne V.ORCID,Busby StephORCID,Allsup DavidORCID,Cohen Judith,Bamidele Olufikayo

Abstract

Introduction Haematological malignancies are a heterogenous group of blood and lymphatic cancers. Survivorship care is a similarly diverse term concerning patients’ health and wellbeing from diagnosis to end of life. Survivorship care for patients with haematological malignancies has traditionally been consultant-led and secondary care-based, although shifts away from this model have been occurring, largely via nurse-led clinics and interventions with some remote monitoring. However, there remains a lack of evidence regarding which model is most appropriate. Although previous reviews exist, patient populations, methodologies, and conclusions are varied, and further high-quality research and evaluation has been recommended. Aims The aim of the scoping review this protocol describes is to summarise current evidence on the provision and delivery of survivorship care for adult patients diagnosed with a haematological malignancy, and to identify existing gaps to inform future research. Methodology A scoping review will be carried out utilising Arksey and O’Malley’s guidelines as its methodological framework. Studies published in the English language from December 2007 to the present will be searched on bibliographic databases, including Medline, CINAHL, PsycInfo, Web of Science, and Scopus. Papers’ titles, abstracts, and full text will predominantly be screened by one reviewer with a second reviewer blind screening a proportion. Data will be extracted using a customised table developed in collaboration with the review team, and presented in tabular and narrative format, arranged thematically. Studies included will contain data regarding adult (25+) patients diagnosed with any haematological malignancy in combination with aspects related to survivorship care. The survivorship care elements could be delivered by any provider within any setting, but should be delivered pre- or post-treatment, or to patients on a watchful waiting pathway. Registration The scoping review protocol has been registered on the Open Science Framework (OSF) repository Registries (https://osf.io/rtfvq; DOI: 10.17605/OSF.IO/RTFVQ).

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. In vitro modeling of non-solid tumors: how far can tissue engineering go?;S Clara-Trujillo;Int J Mol Sci,2020

2. National Institute for Health and Care Excellence. Haematological cancers: improving outcomes [Internet]. [London]: NICE; 2016 [cited 2022 Oct 12]. (Clinical guideline [NG47]). Available from: https://www.nice.org.uk/guidance/ng47

3. Haematological Malignancy Research Network. Classification of haematological malignancies. [cited 2022 Oct 12]. In: Haematological Malignancies [Internet]. York: HMRN. Available from: https://hmrn.org/about/classification

4. Cancer Research UK. Cancer incidence for common cancers. 2020 Mar 5 [cited 2022 Oct 12]. In: Cancer Incidence Statistics [Internet]. Oxford: CRUK. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared

5. Cohort profile: the Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort;A Smith;Int J Epidemiol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3